[MDGL] YoY Quarter Result on 31-Mar-2017 [#Q1]

Stock
[MDGL] Madrigal Pharmaceuticals, Inc.
Announcement Date
11-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- 22.58%
YoY- 8.05%
Quarter Report
MDGL's Result
MDGL's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -36,135 -15,080 -6,364 -5,999 -6,524 -20,707 -23,557 7.38%
Tax 0 0 0 0 0 0 0 -
NP -36,135 -15,080 -6,364 -5,999 -6,524 -20,707 -23,557 7.38%
Tax Rate - - - - - - - -
Total Cost 36,135 15,080 6,364 5,999 6,524 20,707 23,557 7.38%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -2.34 -0.98 -0.45 -0.50 -37.03 -6.69 -9.65 -21.01%
EPS Diluted -2.34 -0.98 -0.45 -0.50 -37.03 -6.69 -9.65 -21.01%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.